Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nationwide Children's Hospital
Nationwide Children's Hospital
M.D. Anderson Cancer Center
Northwestern University
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
NRG Oncology
University of Nebraska
Northwell Health
Erasmus Medical Center
University of Nebraska
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, San Francisco
University of Göttingen
M.D. Anderson Cancer Center
Sun Yat-sen University
Massachusetts General Hospital
NRG Oncology
Northwestern University
Northwestern University
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Huashan Hospital
Medical University of South Carolina
University of California, San Francisco
Dr. Negrin University Hospital
Mashhad University of Medical Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ohio State University Comprehensive Cancer Center
Sun Yat-sen University
University of California, San Francisco
Ohio State University Comprehensive Cancer Center
Beth Israel Medical Center
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
NYU Langone Health
Martin-Luther-Universität Halle-Wittenberg
Duke University
Duke University
Sun Yat-sen University
Duke University
Marmara University
Duke University
Duke University
Duke University
Duke University
Memorial Sloan Kettering Cancer Center
Duke University